Browsing by Author Vranckx, Pascal

فهرست الفبایی 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 6 of 6
PreviewIssue DateTitleAuthor(s)
2018 EHJ Volume 39 Issue 2 January (14).pdf.jpg20182017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST -segment elevation The Task Force for the management of acute myocardial infarctionUk, Chiara Bucciarelli-ducci; Germany, Gerhard Hindricks; Germany, Adnan Kastrati; Lenzen, Mattie J; Denmark, Eva Prescott; Vranckx, Pascal
2018 AHJ Volume 196 February (12).pdf.jpg2018Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention ( PCI ) with stent placement : Rationale and design of the ENTRUST-AF PCI trialVranckx, Pascal; Valgimigli, Marco; Tijssen, G; Reimitz, Paul-egbert; Eckardt, Lars
medicine article k (312).pdf.jpg2013Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint steValgimigli, Marco; Patialiakas, Athanasios; Thury, Attila; Colangelo, Salvatore; Campo, Gianluca; Tebaldi, Matteo; Ungi, Imre; Tondi, Stefano; Roffi, Marco; Menozzi, Alberto; De Cesare, Nicoletta; Garbo, Roberto; Meliga, Emanuele; Testa, Luca; Gabriel, Henrique M.; Airoldi, Flavio; Ferlini, Marco; Liistro, Francesco; Dellavalle, Antonio; Vranckx, Pascal; Briguori, Carlo
2016 AHJ Volume 175 May (10).pdf.jpg2016Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease , non – ST-segment elevation acute coronary syndrome , and ST-segment elevation myocardial infarctionPilgrim, Thomas; Vranckx, Pascal; Valgimigli, Marco; Stefanini, Giulio G
2017 AHJ Volume 184 February (3).pdf.jpg2017Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO studyWindecker, Stephan; Tijssen, Jan; Giustino, Gennaro; Guimar??es, Ana H C; Mehran, Roxana; Valgimigli, Marco; Vranckx, Pascal; Welsh, Robert C.; Baber, Usman; van Es, Gerrit Anne; Wildgoose, Peter; Volkl, Albert a.; Zazula, Ana; Thomitzek, Karen; Hemmrich, Melanie; Danga
2017 AHJ Volume 190 August (12).pdf.jpg2017Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortiumSeltzer, Jonathan H.; Heise, Ted; Carson, Peter; Canos, Daniel; Hiatt, Jo Carol; Vranckx, Pascal; Christen, Thomas; Cutlip, Donald E.